Resources Contact Us Home
Antisense oligonucleotides targeted to human CDC45

Image Number 4 for United States Patent #7393950.

Antisense oligonucleotides that inhibit expression of human replication-initiation protein as well as methods of preventing or treating hyperproliferative conditions using said oligonucleotides are disclosed. One aspect provides an antisense oligonucleotides that inhibits the expression of human replication-initiation protein and has a sequence complementary to at least a portion of a target sequence encoding a human replication-initiation gene. By administering a therapeutically effective amount of antisense oligonucleotides or by contacting the hyperproliferating cells with an effective amount of antisense oligonucleotides, expression of replication-initiation protein is inhibited. Methods of screening and testing active antisense oligonucleotides for their ability to inhibit gene expression are also disclosed.

  Recently Added Patents
All-angle light emitting element having high heat dissipating efficiency
Dynamic load profiling in a power network
Cavernous nerve stimulation via unidirectional propagation of action potentials
Antibodies to Clostridium difficile toxins
System and method for computational unification of heterogeneous implicit and explicit processing elements
Dielectric insulation medium
Method and apparatus for managing communication services for user endpoint devices
  Randomly Featured Patents
Window and door glass protection system and method
Control handle for surgical irrigation and suction device
Route finding in communication networks
Method for mask repair using defect compensation
Agents and methods for treatment and diagnosis of ocular disorders
Pay telephone
Corrosion inhibitors
Image reading apparatus and focusing control method
Electronic component
Process and apparatus for producing non-woven webs of strong filaments